GLOBAL EARNINGS ANALYSIS

Read the story behind the quarter.

Income statement, balance sheet, and cash flow—connected to the customer situation, marketing choices, operating indicators, and real competitive alternatives.

POPULAR & RECENT

Five reports to start with

FY2026 · MDT

Medtronic FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin

Medtronic reported $36.4B in revenue and $6.5B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.

Read earnings analysis →FY2026 · STE

STERIS FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin

STERIS reported $5.9B in revenue and $1.1B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.

Read earnings analysis →FY2026 · CRVL

CorVel FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin

CorVel reported $959M in revenue and $110M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.

Read earnings analysis →FY2026 · HAE

Haemonetics FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin

Haemonetics reported $1.3B in revenue and $157M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.

Read earnings analysis →FY2026 · DOCS

Doximity FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin

Doximity reported $645M in revenue and $215M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.

Read earnings analysis →

121 earnings analyses

Primary sources · US GAAP · USD millions

FY2025 · NEOG

Neogen FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin

Neogen reported $895M in revenue and -$1.1B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.

Read earnings analysis →